Creating pomegranate drug to stem Alzheimer’s, Parkinson’s

Research will look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation and slow down the progression of Alzheimer’s disease, scientists report. The onset of Alzheimer’s disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate. Also, the painful inflammation that accompanies illnesses such as rheumatoid arthritis and Parkinson’s disease could be reduced, according to the findings of the two-year project.

Leave a Reply

Your email address will not be published. Required fields are marked *